PTH Among Health Care ETFs
End-of-day Nov 16, 2026 · 39 Health care ETFs by 1W
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.5% | −6.7% | 0.0% | −8.0% | +12.5% | +21.1% | +90.5% | +4.9% | +595.3% |
| Peer average | −1.5% | −3.2% | +4.0% | +1.6% | +19.6% | +25.3% | +73.9% | +24.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$42 of every $1,000 in PTH is Roivant
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ROIVRoivant Sciences | Healthcare | 4.23% | $423.06 | 301K | $11.9M |
| 2 | THCTenet Healthcare | Healthcare | 4.14% | $413.65 | 41K | $11.6M |
| 3 | INSMInsmed | Healthcare | 3.99% | $399.43 | 93K | $11.2M |
| 4 | GHGuardant Health | Healthcare | 3.44% | $344.25 | 64K | $9.7M |
| 5 | RVMDRevolution Medicines | Healthcare | 3.36% | $336.27 | 55K | $9.5M |
| 6 | AXGNAxogen | Healthcare | 3.17% | $317.26 | 160K | $8.9M |
| 7 | NTRANatera | Healthcare | 3.08% | $308.18 | 27K | $8.7M |
| 8 | MEDPMedpace | Healthcare | 3.05% | $305.37 | 13K | $8.6M |
| 9 | TXG10X Genomics | Healthcare | 2.96% | $295.85 | 143K | $8.3M |
| 10 | HNGEHinge Health | Healthcare | 2.92% | $291.84 | 71K | $8.2M |
| 11 | EXELExelixis | Healthcare | 2.88% | $287.55 | 117K | $8.1M |
| 12 | IOVAIovance Biotherapeutics | Healthcare | 2.75% | $274.79 | 996K | $7.7M |
| 13 | CDNACareDx | Healthcare | 2.54% | $254.35 | 92K | $7.2M |
| 14 | CRLCharles River Laboratories International | Healthcare | 2.44% | $243.76 | 20K | $6.9M |
| 15 | PACSPACS Group | Healthcare | 2.30% | $229.87 | 134K | $6.5M |
of the $113B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ROIV | Roivant Sciences | 4.23% |
| 2 | THC | Tenet Healthcare | 4.14% |
| 3 | INSM | Insmed | 3.99% |
| 4 | GH | Guardant Health | 3.44% |
| 5 | RVMD | Revolution Medicines | 3.36% |
| 6 | AXGN | Axogen | 3.17% |
| 7 | NTRA | Natera | 3.08% |
| 8 | MEDP | Medpace | 3.05% |
| 9 | TXG | 10X Genomics | 2.96% |
| 10 | HNGE | Hinge Health | 2.92% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 26, 2025 | $1.53 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0255 |
| Dec 20, 2013 | Dec 31, 2013 | $0.0114 |
| Sep 20, 2013 | Sep 30, 2013 | $0.0027 |
| Jun 21, 2013 | Jun 28, 2013 | $0.0368 |
| Dec 21, 2012 | Dec 31, 2012 | $0.11 |
| Jun 15, 2012 | Jun 29, 2012 | $0.0084 |
| Dec 18, 2009 | Dec 31, 2009 | $0.0194 |
| Jun 19, 2009 | Jun 30, 2009 | $0.0083 |